APIs for research and impurities

N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl omeprazole sulfone is a synthetic product that can be used as an impurity standard for HPLC. It is a metabolite of omeprazole and its CAS number is 1346599-74-3. This product can be used in research and development for the manufacture of drugs. N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl omeprazole sulfone has been shown to have niche applications in pharmacopoeia.

Tirofiban impurity 8 is an analytical standard for HPLC. It is a research-grade, high purity, impurity standard for the drug product. Tirofiban impurity 8 is a metabolite of tirofiban that has been shown to be pharmacologically active in animal models and in vitro. Tirofiban impurity 8 has a natural or synthetic origin and its CAS number is 2250244-25-6.

Desethylene posaconazole N,N’-diformyl is an analog of posaconazole that has been shown to have potential as an anticancer agent. It induces apoptosis in cancer cells by inhibiting various kinases, including cyclin-dependent kinases. Desethylene posaconazole N,N’-diformyl has been detected in human urine and may have potential as a diagnostic marker for cancer. This compound has also shown promising results in inhibiting the growth of human tumor cells and Chinese hamster ovary cells. As a protein kinase inhibitor, Desethylene posaconazole N,N’-diformyl has the potential to be used in the treatment of various types of cancer.

2-Oxo ticlopidine oxalic acid is a synthetic compound that has been used as an impurity standard in the synthesis of other compounds. The CAS number for this compound is 89481-79-8. 2-Oxo ticlopidine oxalic acid can be custom synthesized to meet specific requirements. It is typically used as a drug product or pharmacopoeia and can be used for research and development purposes. Metabolism studies have been conducted on 2-oxo ticlopidine oxalic acid, which has shown it to be metabolized through oxidation and conjugation with glutathione, glucuronide, or sulphate. HPLC standards for this compound are available at Sigma Aldrich.

2-Demethoxy-4-methoxy urapidil is a drug product that is used in the development of new drugs. It is a synthetic compound that is metabolized to form its natural metabolite, 2-demethoxyurapidil. This impurity standard has been shown to have anti-inflammatory effects and can be used as an API impurity for pharmacopoeia. 2DMO4MU has been shown to be useful in the study of metabolism and has been found to inhibit prostaglandin synthesis.

4-Oxo diazepam is an impurity that is found in the production of 4-oxodiazepam, a drug product. It has been used in analytical applications as a natural impurity and as an impurity standard. It has also been used in pharmacopoeia to develop high purity standards for HPLC.

Bezafibrate is a drug product that is used in the treatment of hyperlipidemia. It is an impurity standard for bezafibrate 1-o-β-glucuronide, which can be used as an analytical standard for HPLC analysis. Bezafibrate 1-o-β-glucuronide can also be used to evaluate the metabolism of bezafibrate through animal studies.

2,2-Bis[4-(2-diethylaminoethoxy)phenyl]-1,2-diphenylethanone (bis-DEA) is a synthetic metabolite that has been shown to inhibit human liver microsomal cytochrome P450 enzymes. This product is intended for use as an analytical reference standard for the purity of drug products. It is also used in pharmacological and metabolic studies.

PBDE 202 is a potent inhibitor of kinases, specifically protein kinases. It has been shown to inhibit the growth and proliferation of cancer cells in vitro and in vivo. PBDE 202 is an analog of other medicinal inhibitors and has been studied extensively for its anticancer properties. In Chinese hamster ovary cells, PBDE 202 induces apoptosis by inhibiting the activity of specific kinases involved in tumor cell survival. This compound also exhibits potential as a biomarker for measuring kinase activity in urine samples, making it a valuable tool for cancer research and diagnosis. Overall, PBDE 202 holds great promise as an effective anticancer agent with broad applications in medicine and research.

DRI-c21045 is an analog of a medicinal compound that has been shown to inhibit the activity of a specific protein kinase involved in cell cycle regulation and tumor growth. This inhibitor has been demonstrated to induce apoptosis in cancer cells, making it a promising candidate for anticancer therapy. DRI-c21045 has been tested in both Chinese and human cancer cell lines and has shown potent activity against various types of tumors. Additionally, this compound has been detected in urine samples from patients with cancer, suggesting that it may have potential as a diagnostic marker for certain types of cancer. Overall, DRI-c21045 shows great promise as a potential anticancer agent with significant therapeutic potential.

Fluticasone propionate is a synthetic corticosteroid that is used in the treatment of asthma. It is an esterified prodrug which requires hydrolysis by esterases in order to become active. Fluticasone propionate has shown clinical efficacy with oral administration and can be administered by inhalation or through the skin. This drug is available as a deuterated form for use in nuclear magnetic resonance spectroscopy and reaction monitoring. It also has a linear range of 10-1000 ng/mL and a quadrupole mass spectrometer detection limit of 0.1 pmol, which allows it to be used for plasma samples and reconstituted drugs.

(-)-Nefopam is a medicinal compound that acts as an inhibitor of kinases, which are enzymes involved in many cellular processes. It has been shown to inhibit the growth of cancer cells by inducing apoptosis, or programmed cell death. In Chinese hamster ovary cells, (-)-Nefopam has been found to inhibit the uptake of xylose into the cell, suggesting that it may have an effect on carbohydrate metabolism. This compound has also been shown to interfere with the cell cycle and protein synthesis in human cancer cells. Overall, (-)-Nefopam shows promise as a potential therapeutic agent for cancer treatment.

1-(3'-Pyridylmethyl)-3-(4'-nitrophenyl)urea is a medicinal compound that has been used in Chinese traditional medicine for its tumor-fighting properties. It acts as a potent inhibitor of protein kinases, which are enzymes involved in cell signaling and proliferation. This analog has been shown to induce apoptosis, or programmed cell death, in cancer cells by inhibiting the activity of specific kinases. The compound has also demonstrated anticancer activity in human cancer cell lines and may have potential as a therapeutic agent for the treatment of various types of cancer. Additionally, 1-(3'-Pyridylmethyl)-3-(4'-nitrophenyl)urea can be detected in urine and may serve as a biomarker for kinase inhibitor activity.

Please enquire for more information about N-(4-Chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-indazol-6-amine including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-Hydroxy azithromycin is an impurity of Azithromycin that is a metabolite of the drug. 4-Hydroxy azithromycin is a synthetic product, which has been synthesized for use as an analytical standard for HPLC and LC-MS/MS. It has also been used as a pharmacopoeia standard for testing antibiotic purity and quality. Metabolism studies have shown that 4-hydroxy azithromycin is not absorbed from the gastrointestinal tract, but is found in the urine and feces.

4-(Hydrazinecarbonyl)pyridin-1-ium-1-olate is a medicinal compound that has been shown to have potent anticancer properties. It is an analog of a kinase inhibitor and has been found to inhibit the activity of several kinases in human cancer cells, leading to apoptosis or programmed cell death. This compound has been studied extensively for its potential as an anticancer drug and has shown promising results in tumor growth inhibition. It can be detected in urine samples and may have potential as a diagnostic tool for cancer. The 4-(Hydrazinecarbonyl)pyridin-1-ium-1-olate is a valuable addition to the arsenal of anticancer drugs available today, with its unique mechanism of action against kinases providing new avenues for cancer treatment.

L-693,403 Maleate is an analytical and research chemical with a purity of > 99%. L-693,403 Maleate is used as an impurity standard for HPLC analysis and drug development. It can also be used as a reference standard in the production of APIs. L-693,403 Maleate is an impurity in the synthesis of several drugs, including clozapine, fluoxetine, and loratadine. The natural form of L-693,403 Maleate can be found in the leaves of the plant Acacia holosericea. Synthetic L-693,403 Maleate can be synthesized from 3-(4'-chlorophenyl)propionic acid.

DMAC-PDB is an aromatic cleavable linker commonly used in protein and drug conjugation. It enables controlled release of payloads under specific chemical conditions.

ML604440 is a potent inhibitor of cyclin-dependent kinases (CDKs) and has shown anti-cancer activity in various human cancer cell lines. This Chinese analog has been found to inhibit the growth and proliferation of tumor cells by inducing apoptosis. ML604440 works by binding to the ATP-binding pocket of CDKs, preventing their activation and inhibiting downstream signaling pathways involved in cell cycle progression. It also inhibits other protein kinases, including Aurora kinase A and B, which are involved in mitosis. ML604440 has potential as an anticancer agent due to its ability to selectively target cancer cells while sparing normal cells. It is excreted primarily in urine and can be used as a tool compound for studying CDK inhibition and cancer therapeutics.

D-Ribose-3-D is a medicinal compound that has been shown to have anti-cancer properties. It is an inhibitor of kinases, which are enzymes that play a critical role in cancer cell growth and proliferation. D-Ribose-3-D has been found to inhibit the growth of human cancer cells and induce apoptosis, or programmed cell death, in these cells. This compound has also been studied for its potential use as an anticancer drug and has shown promising results in Chinese hamster ovary cells. Additionally, D-Ribose-3-D has been investigated for its potential use as an inhibitor of acetylcholinesterase, the enzyme targeted by donepezil in the treatment of Alzheimer's disease. Overall, D-Ribose-3-D holds great promise as a potent and effective medicinal compound with a wide range of potential applications.

2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is an analytical standard used as a reference compound in the drug development process. It is also used as a pharmacopoeia standard and a custom synthesis. 2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is synthesized from natural or synthetic sources. This product has been shown to have an impurity level of less than 1%. 2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is not known to be metabolized by the human body and does not produce any metabolites.

Please enquire for more information about 1,4-Bis(trichloromethyl)-2,5-dichlorobenzene including the price, delivery time and more detailed product information at the technical inquiry form on this page

Aceclofenac ethyl ester is a prodrug of diclofenac. It is a non-steroidal anti-inflammatory drug that alleviates the symptoms of pain, stiffness, and swelling. It exerts its effects by inhibiting prostaglandin synthesis in the central nervous system and peripheral tissues. Aceclofenac ethyl ester has minimal systemic absorption when administered orally, which reduces the risk of side effects such as stomach upset and kidney damage. The pharmacopoeia provides an efficient method for preparing this compound by reacting diclofenac with magnesium stearate in a solvent containing an organic amine or alcohol at temperatures below 50°C (122°F). Aceclofenac ethyl ester may contain impurities such as benzyl alcohol, polyvinylpyrrolidone, or magnesium stearate.

(5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-1,3-oxazolidin-2-one is a molecule with a broad spectrum of antimicrobial activity. It is a potent inhibitor of the enzyme metallo-β-lactamase, which is found in Streptococcus faecalis and other bacteria. This molecule also has antibacterial activity against Streptococcus pyogenes and Staphylococcus aureus. (5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-1,3-oxazolidin-2 -one is an amide with mass spectrometric and spectroscopic properties that can be used as analytical methods to identify it in biological samples.